Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits

Clinical Nephrology

Volumn 53, Issue SUPPL. 1, 2000, Pages

  Paulitschke, M ^a,c   Ludat, K ^a   Riedel, E ^b   Hampl Cell Lining Gmbh, H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Cell Lining GmbH   (Germany)

Author keywords

Blood viscosity; Chronic renal failure; Erythrocyte aggregation; Erythrocyte deformability; Erythropoietin; Hemorheology; Renal anemia

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD RHEOLOGY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; MALE; PATHOPHYSIOLOGY; PLASMA VISCOSITY; QUALITY OF LIFE; RISK FACTOR;

ADULT; AGED; BLOOD VISCOSITY; ERYTHROCYTE DEFORMABILITY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOCRIT; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS;

EID: 0034012505     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bäiimler H, Lerche D, Paulitschke M, Meier 1C 1986 Aggregation of red blood cells in hypotonie and Hypertonie salt solution determined by light backscattering technique. Studia biophysica 115: 5-16
2. Bonelli CA 1996 Hematocrit of 40% in patients with chronic renal failure in hemodialysis during a period of 26 months. 33rd EDTA Congress, Amsterdam, 360
3. Crowley JP, Nealey TA, Metzger J, Pono L, Cha:en JA (1987) Transfusion and long-term hemodialysis. Arch Intern Med 147: 1925-1928
4. Eschbach JW, Adamson JW, CookJD 1970 Disorders of red blood cell production in uremia. Arch Intern Med 126:812-815
5. Eschbach Ml', Adamson SW1988 Modern aspects of the pathophysiology of renal anemia. In: Koch KM, Kühn K, Nonnast-Daniel B, Scigalla P: Treatment of renal anemia with recombinant human erythropoietin. Contr Nephrol 66. Karger, Basel, 63-70
6. Eschbach JW, Downing MR, Egrie JC, Browne JK, Adamson JW 1989 USA multicenter clinical trial with recombinant human erythropoietin (Amgcn). In: Baldamus CA, Scigalla P, Wieczorek L, Koch KM 1989 Erythropoietin: From molecular structure to clinical application. Contrib Nephrol 76. Karger, Basel, 160-165
7. European Advisory Board in CRF1996 Maximizing the potential of r-HuEPO. Excerpta Medica, Amsterdam, 1-16
8. Lerche D, Schmidt R. Zoellner K, Meier W, Paulitschke M, DistlerB, Klinkmann H 1989 Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy. In: Baldamus CA, Scigalla P, Wieczorek L, Koch KM Erythropoietin: From molecular structure to clinical application. Contrib Nephrol 76. Karger, Basel, 299-305
9. Lerche D, Bäumler H, Kiicera W, Meier W, Paulitschke M 1991 Flow properties of blood and hemorheological methods of quantification. In: Schutt W, Klinkmann H, Lamprecht I, Wilson T: 1991 Physical characterization of biological cells. Gesundheit, Berlin, 189-214
10. RuefP, PoschJMB, Schreml K, Linderkamp P 1996 The shear stress diffractometer rheodyn SSD for determination of erythrocyte deformability. Clin Hemorheol 16: 64-68
11. NeffMS, Kim KE, Persoff M, Onesti G, Swarlz C 1971 Hemodynamics of urémie anemia. Circulation 43: 876-883
12. Omearls CG, Oliver D. Pippard MJ, Reid C, Downing MR, Cotes PM 1986 Effect of human erythropoietin derived from recombinant DANN on the anemia of patients maintained by chronic hemodialysis. Lancet II: 1175-1178
13. Wolcoff DL, Schweitzer S, Marsh JT 1988 Recombinant erythropoietin improves cognitive function and quality of life of chronic hemodialysis patients. Kidney Int 33: 242-249
14. Zehnder C, Glück Z, Descoendres C, Uehlinger DE, Blumbei'gE 1988 Human recombinant erythropoietin in anemic patients on maintenance hemodialysis. Secondary effects of the increase of hemoglobin. Nephrol Dial Transplant 3: 657-660